In the TCGA breast cancer data, (U.C. Santa Cruz, xenabrowser.net, Nature 2012), two of the factors in this study (PARP1 and CCL2) showed significant overexpression in the Basal type of tumors concerning the Luminal-A or B subtype (Figure S7) [28]. This evidence concerns the gene CCL2 and breast carcinoma.